Pfizer Inc.
Cash Flow Statement
| Line Item | Jul 2022 | Apr 2022 | Dec 2021 | Oct 2021 | Jul 2021 | Apr 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $9.91B | $7.86B | $3.39B | $8.15B | $5.56B | $4.88B | $846.0M | $1.47B |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $287.0M | $86.0M | $496.0M | $293.0M | $221.0M | $172.0M | $287.0M | $224.0M |
| Net Cash from Operating Activities | $8.17B | $6.54B | $5.91B | $10.83B | $11.30B | $4.54B | $5.63B | $2.09B |
| Investing Activities | ||||||||
| Capital Expenditures | $751.0M | $643.0M | $1.00B | $618.0M | $537.0M | $554.0M | $813.0M | $507.0M |
| Business Acquisitions | $0 | $6.23B | $0 | $0 | $0 | $0 | — | — |
| Net Cash from Investing Activities | $-11.31B | $567.0M | $-2.59B | $-10.08B | $-8.14B | $-1.75B | $8.33B | $481.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $2.00B | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing Activities | $2.52B | $-6.58B | $-3.35B | $-1.10B | $-2.56B | $-2.81B | $-13.79B | $-2.82B |
| Net Change in Cash | $-688.0M | $529.0M | $-50.0M | $-384.0M | $608.0M | $-15.0M | $198.0M | $-218.0M |
| Free Cash Flow | $7.42B | $5.90B | $4.91B | $10.21B | $10.76B | $3.98B | $4.81B | $1.58B |